Brain :: NIH funding UIC brain tumor research
Researchers at the University of Illinois at Chicago College of Pharmacy have received a $1.7 million five-year federal grant to develop a new approach to treat brain tumors.
Researchers at the University of Illinois at Chicago College of Pharmacy have received a $1.7 million five-year federal grant to develop a new approach to treat brain tumors.
Increasing the amount of SUMO, a small protein in the brain, could be a way of treating diseases such as epilepsy and schizophrenia, reveal scientists at the University of Bristol, UK. Their findings are published online today in Nature.
Everyday experience and psychology research both indicate that paying close attention to one thing can keep you from noticing something else. However, a new study from the University of Wisconsin-Madison suggests that attention does not have a fixed capacity — and that it can be improved by directed mental training, such as meditation.
The likelihood of developing bipolar disorder depends in part on the combined, small effects of variations in many different genes in the brain, none of which is powerful enough to cause the disease by itself, a new study shows. However, targeting the enzyme produced by one of these genes could lead to development of new, more effective medications.
Scientists have developed a novel strategy for tackling neurodegenerative diseases such as Huntington’s disease: encouraging an individual’s own cells to “eat” the malformed proteins that lead to the disease.
Eight years ago, the field of anthropology was rocked by isotopic evidence that suggested one-third of the diet of early human ancestors consisted of grasses and sedges, or the tissue of animals that ate such plants. The news puzzled scientists, who were unable to reconcile the results with what they knew about the teeth of human ancestors who lived more than 2 million years ago.
Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc. (NYSE: BRL), announced that it received final U.S. Food & Drug Administration (FDA) approval for its application to manufacture and market a generic version of Bayer Pharmaceuticals Corporation’s Nimotop(R) (nimodipine) Capsules, 30 mg.
When we have a conversation with someone, we not only hear what they say, we see what they say. Eyes can smolder or twinkle. Gazes can be direct or shifty. “Reading” these facial expressions gives context and meaning to the words we hear.
Parkinson’s disease is well-known for its progression of motor disorders: stiffness, slowness, tremors, difficulties walking and talking. Less well known is that Parkinson’s shares other symptoms with narcolepsy, a sleep disorder characterized by sudden and uncontrollable episodes of deep sleep, severe fatigue and general sleep disorder.
A team led by UCSF scientists has received a grant of $15 million, provided over five years, to study the complex genetic factors that underlie some of the most common forms of epilepsy.